Clinical Trials Browser

Unknown × Advanced Cancer × Other solid neoplasm × Clear all

NCT02797795 2021-03-03

A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers

Phase 1 Unknown

Other solid neoplasm

Advanced Cancer